Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTREAT Trial: Prophylactic Antiemetic Treatment of Opioid-Induced Nausea and Vomiting in Palliative Care
DRKS00024954Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Opioid-induced nausea and vomiting (OINV) comparing Palonosetron prophylaxis with Placebo prophylaxis (2 arms). Started Mar 2022; status: completed.
02
Drugs
palonosetron
03
Conditions
Opioid-induced nausea and vomiting (OINV)
Beyond the preview
Go deeper on DRKS00024954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024954.